Overview
High-Quality Acute Myeloid Leukemia PBMC for Research
Acute Myeloid Leukemia (AML) PBMC products are sourced from donors clinically diagnosed with acute myeloid leukemia (AML) and processed under stringent conditions to support immune response in oncology research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on immune response and biomarker identification.
Product Features
- Research Use Only (RUO), cryopreserved AML PBMC Samples
- Clinically confirmed AML donors
- Processed within 24 hours of collection
- Stored using CryoStore® CS10 freezing media
- IRB-approved protocols and electronic informed consent
Donor Metadata
- Verified AML diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional acute myeloid leukemia (aml)-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in AML pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Acute Myeloid Leukemia PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact [email protected] to confirm documentation and compliance needs.
Protocols and Documentation
Publications
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.